Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > PEA assumptions

<< Previous

Bullboard Posts

Next >>

Post by lscfaon May 04, 2024 10:14am

162 Views

Post# 36023131

PEA assumptions

This is based on feedstock from mine. Who knows what volumes co. expects using 3rd party feedstock.

				Year 1 PEA
Year 1 PEA	Bottles	Tonnes	Price	Revenue
Smooth x	5,600,000		5	28,000,000
HDX	95,000		7.5	712,500
LDX	79,000		6.5	513,500
Multithick	1,000		22.5	22,500
Multi thin	1,000		19.5	19,500
				29,268,000